For more detailed information, you can refer to the article through this URL: High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri The study High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri by Liu GT, Glaser JS, Schatz NJ, published in American Journal of Ophthalmology in 1994, explores the effectiveness of a treatment regimen involving high doses of methylprednisolone and acetazolamide for acute, severe visual loss associated with pseudotumor cerebri
Secondary endpoints included the percentage of patients with on-treatment virologic failure and posttreatment relapse
If your prescriber recommends a switch, pay attention to the differences in: Product form Storage Expiration The method of administering doses Safety Risks Are Tied To Cheaper Or Off-Label Products Lower cost does not equate to safety
Problem: My serum turned dark blue and smells metallic
Laboratory tested quality
Proc Natl Acad Sci U S A 105: 95829587
